Development and production of a diagnostic kit for the SARS-CoV-2 virus by RT-PCR

  • Funded by International Centre for Genetic Engineering and Biotechnology (ICGEB)
  • Total publications:0 publications

Grant number: CRP/DZA20-03

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    -99
  • Known Financial Commitments (USD)

    $0
  • Funder

    International Centre for Genetic Engineering and Biotechnology (ICGEB)
  • Principal Investigator

    Mohammed Sebaihia
  • Research Location

    Algeria
  • Lead Research Institution

    University Hassiba Benbouali
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

There is little doubt that accurate pathogen detection methods are fundamental to any public health strategies aimed at monitoring and limiting the spread of infectious diseases. This is best illustrated by the current COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2. The World Health Organization has made it abundantly clear that comprehensive testing is the most effective way to prevent infections and save lives. Of the currently available methods for the detection of SARS-CoV-2, the RT-qPCR is considered to be the gold standard. However, the deployment of RT-qPCR tests has been rather variable internationally due to the high global demand and the interruption of the supply chain; and thus, many developing countries, including Algeria, have experienced severe shortages of these kits, which has limited their testing capabilities. The main objective of this project is to produce locally all the enzymes, primers and probes necessary for cost-effective RTqPCR kits